EBIT Margin: Earnings before interest and taxes as a portion of total revenues. Calculated as: EBIT / Total Revenues
ENDRA Life Sciences Inc. (NDRA) EBIT Margin data is not available for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-1.31M |
|
-- |
|
-- |
|
$2.17M |
|
$-2.17M |
|
$0.86M |
|
$-1.31M |
|
$-1.31M |
|
$-1.31M |
|
$-1.31M |
|
$-1.31M |
|
$-1.31M |
|
$-2.17M |
|
$-2.13M |
|
1.20M |
|
1.20M |
|
$-1.09 |
|
$-1.09 |
|
| Balance Sheet Financials | |
$0.54M |
|
$0.03M |
|
$2.90M |
|
$3.44M |
|
$0.84M |
|
-- |
|
$0.82M |
|
$1.65M |
|
$1.79M |
|
$1.79M |
|
$1.79M |
|
1.24M |
|
| Cash Flow Statement Financials | |
$-1.12M |
|
$0.45M |
|
$0.26M |
|
$0.76M |
|
$0.36M |
|
$-0.41M |
|
$0.57M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.64 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
EBIT Margin |
-- |
-- |
|
-- |
|
-- |
|
$-1.12M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-73.39% |
|
-73.39% |
|
-38.14% |
|
-73.39% |
|
$1.44 |
|
$-0.93 |
|
$-0.93 |
|